The Inventing Press

UNITEDHEALTH GROUP INC

Financial highlights

MetricFY 12/31/25FY 12/31/24FY 12/31/23FY 12/31/22FY 12/31/21
Income Statement
Revenue$447.6B$400.3B$371.6B$324.2B$287.6B
Selling, general & administrative$59.6B$53.0B$54.6B$47.8B$42.6B
Operating income$19.0B$32.3B$32.4B$28.4B$24.0B
Interest expense$4.0B$3.9B$3.2B$2.1B$1.7B
Pretax income$14.7B$20.1B$29.1B$26.3B$22.3B
Income tax expense$1.9B$4.8B$6.0B$5.7B$4.6B
Net income$12.1B$14.4B$22.4B$20.1B$17.3B
Balance Sheet
Cash and equivalents$24.4B$25.3B$25.4B$23.4B$21.4B
Current assets$90.6B$85.8B$78.4B$69.1B$61.8B
Total assets$309.6B$298.3B$273.7B$245.7B$212.2B
Current liabilities$114.9B$103.8B$99.1B$89.2B$78.3B
Total liabilities$207.9B$195.7B$174.8B$159.4B$135.7B
Total debt$77.7B$76.2B$61.5B$56.8B$44.6B
Stockholders' equity$100.1B$98.3B$94.4B$81.5B$75.0B
Cash Flow Statement
Cash from operations$19.7B$24.2B$29.1B$26.2B$22.3B
Depreciation and amortization$1.0B$1.0B$1.1B$1.1B$1.0B
Stock-based compensation$971.0M$1.0B$1.1B$925.0M$800.0M
Capital expenditure$3.6B$3.5B$3.4B$2.8B$2.5B
Free cash flow$16.1B$20.7B$25.7B$23.4B$19.9B
Dividends paid$7.9B$7.5B$6.8B$6.0B$5.3B
Share repurchases$5.5B$9.0B$8.0B$7.0B$5.0B
Impairments$0$0$0$0$0

Shares outstanding 908.1M · Free float 93.4%

Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.

Recent filings

  • July 16, 2026 8-K
  • June 5, 2026 8-K
  • May 11, 2026 8-K
  • May 5, 2026 10-Q
  • April 21, 2026 8-K
  • March 9, 2026 8-K
  • March 2, 2026 8-K
  • March 2, 2026 10-K

Earnings